A Novel Vaccine Trial for Children with Rare Brain Cancer, DIPG with Ashley Plant-Fox, MD and Michael DeCuypere, MD, PhD
Precision · Ann & Robert H. Lurie Children's Hospital of Chicago
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Diffuse intrinsic pontine glioma, known as DIPG, is a rare and aggressive type of pediatric cancer that forms in the brainstem, resulting in approximately 200 to 300 new cases in the United States each year. Fortunately, investigators at Lurie Children's Hospital are paving the way to breakthrough treatment for children with DIPG. In this episode, Lurie Children's physicians Dr. Ashley Plant-Fox and Dr. Michael DeCuypere discuss the progress of this first-of-its-kind, phase 1 clinical trial for DIPG that has been open since January of 2022 and offers hope for a disease that currently has no curative options.